Publication:
Acetaminophen-Induced Liver Injury Alters the Acyl Ethanolamine-Based Anti-Inflammatory Signaling System in Liver.

dc.contributor.authorRivera, Patricia
dc.contributor.authorPastor, Antoni
dc.contributor.authorArrabal, Sergio
dc.contributor.authorDecara, Juan
dc.contributor.authorVargas, Antonio
dc.contributor.authorSanchez-Marin, Laura
dc.contributor.authorPavon, Francisco J
dc.contributor.authorSerrano, Antonia
dc.contributor.authorBautista, Dolores
dc.contributor.authorBoronat, Anna
dc.contributor.authorde-la-Torre, Rafael
dc.contributor.authorBaixeras, Elena
dc.contributor.authorLucena, M Isabel
dc.contributor.authorde-Fonseca, Fernando R
dc.contributor.authorSuarez, Juan
dc.contributor.funderInstituto de Salud Carlos III (ISCIII)
dc.contributor.funderMinisterio de Economía y Competitividad (MINECO) c
dc.contributor.funderMinisterio de Sanidad, Servicios Sociales e Igualdad and Plan Nacional sobre Drogas
dc.contributor.funderConsejería de Economía, Innovación y Ciencia, Junta de Andalucía, UE-ERDF
dc.contributor.funderConsejería de Salud, Junta de Andalucía
dc.date.accessioned2023-01-25T10:01:03Z
dc.date.available2023-01-25T10:01:03Z
dc.date.issued2017-10-06
dc.description.abstractProtective mechanisms against drug-induced liver injury are actively being searched to identify new therapeutic targets. Among them, the anti-inflammatory N-acyl ethanolamide (NAE)-peroxisome proliferators activated receptor alpha (PPARα) system has gained much interest after the identification of its protective role in steatohepatitis and liver fibrosis. An overdose of paracetamol (APAP), a commonly used analgesic/antipyretic drug, causes hepatotoxicity, and it is being used as a liver model. In the present study, we have analyzed the impact of APAP on the liver NAE-PPARα system. A dose-response (0.5-5-10-20 mM) and time-course (2-6-24 h) study in human HepG2 cells showed a biphasic response, with a decreased PPARα expression after 6-h APAP incubation followed by a generalized increase of NAE-PPARα system-related components (PPARα, NAPE-PLD, and FAAH), including the NAEs oleoyl ethanolamide (OEA) and docosahexaenoyl ethanolamide, after a 24-h exposure to APAP. These results were partially confirmed in a time-course study of mice exposed to an acute dose of APAP (750 mg/kg). The gene expression levels of Pparα and Faah were decreased after 6 h of treatment and, after 24 h, the gene expression levels of Nape-pld and Faah, as well as the liver levels of OEA and palmitoyl ethanolamide, were increased. Repeated APAP administration (750 mg/kg/day) up to 4 days also decreased the expression levels of PPARα and FAAH, and increased the liver levels of NAEs. A resting period of 15 days completely restored these impairments. Liver immunohistochemistry in a well-characterized human case of APAP hepatotoxicity confirmed PPARα and FAAH decrements. Histopathological and hepatic damage (Cyp2e1, Caspase3, αSma, Tnfα, and Mcp1)-related alterations observed after repeated APAP administration were aggravated in the liver of Pparα-deficient mice. Our results demonstrate that the anti-inflammatory NAE-PPARα signaling system is implicated in liver toxicity after exposure to APAP overdose, and may contribute to its recovery through a long-term time-dependent response.
dc.description.sponsorshipThis work was supported by Instituto de Salud Carlos III (ISCIII), Ministerio de Economía y Competitividad (MINECO) co-funded by UE-ERDF program (JS: PI16/01374; FdF: PI16/01698 and RD16/0017/0001); Ministerio de Sanidad, Servicios Sociales e Igualdad and Plan Nacional sobre Drogas (JS: PNSD2015/047); Consejería de Economía, Innovación y Ciencia, Junta de Andalucía, UE-ERDF (FdF: CTS-8221); Consejería de Salud, Junta de Andalucía, UE-ERDF (FdF: SAS111224; PR: PI-0337-2012); and DIUE, Generalitat de Catalunya (RdT: 2014 SGR 680). FP (CP14/00212), AS (CP14/00173), and JS (CP12/03109) are recipients of a research contract from “Miguel Servet” Program of ISCIII and EU-ERDF. PR holds a “Sara Borrel” research contract from the National System of Health, ISCIII (CD16/00067).
dc.description.versionSi
dc.identifier.citationRivera P, Pastor A, Arrabal S, Decara J, Vargas A, Sánchez-Marín L, et al. Acetaminophen-Induced Liver Injury Alters the Acyl Ethanolamine-Based Anti-Inflammatory Signaling System in Liver. Front Pharmacol. 2017 Oct 6;8:705
dc.identifier.doi10.3389/fphar.2017.00705
dc.identifier.issn1663-9812
dc.identifier.pmcPMC5635604
dc.identifier.pmid29056914
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635604/pdf
dc.identifier.unpaywallURLhttps://www.frontiersin.org/articles/10.3389/fphar.2017.00705/pdf
dc.identifier.urihttp://hdl.handle.net/10668/11713
dc.journal.titleFrontiers in pharmacology
dc.journal.titleabbreviationFront Pharmacol
dc.language.isoen
dc.organizationInstituto de Investigación Biomédica de Málaga-IBIMA
dc.organizationHospital Universitario Virgen de la Victoria
dc.organizationHospital Universitario Regional de Málaga
dc.page.number16
dc.provenanceRealizada la curación de contenido 20/02/2025
dc.publisherFrontiers Research Foundation
dc.pubmedtypeJournal Article
dc.relation.projectIDPI16/01374
dc.relation.projectIDRD16/0017/0001
dc.relation.projectIDPNSD2015/047
dc.relation.projectIDCTS-8221
dc.relation.projectIDSAS111224
dc.relation.publisherversionhttps://doi.org/10.3389/fphar.2017.00705
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectFAAH
dc.subjectOEA
dc.subjectPPARα
dc.subjectHepatic injury
dc.subjectParacetamol
dc.subjectToxicity
dc.subject.decsAcetaminofén
dc.subject.decsReceptores activados del proliferador del peroxisoma
dc.subject.decsHígado
dc.subject.decsExpresión génica
dc.subject.decsDosificación
dc.subject.decsCirrosis hepática
dc.subject.meshPeroxisome Proliferators
dc.subject.meshAntipyretics
dc.subject.meshPPAR alpha
dc.subject.meshCytochrome P-450 CYP2E1
dc.subject.meshHep G2 Cells
dc.subject.meshImmunohistochemistry
dc.subject.meshLiver Diseases
dc.titleAcetaminophen-Induced Liver Injury Alters the Acyl Ethanolamine-Based Anti-Inflammatory Signaling System in Liver.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number8
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC5635604.pdf
Size:
6.25 MB
Format:
Adobe Portable Document Format